Evaluate Reduction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Reduction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Reduction Today - Breaking & Trending Today

Ziltivekimab reduced inflammatory biomarkers associated with atherosclerosis in people with chronic kidney disease in phase 2 trial

Published: May 17, 2021

/PRNewswire/ -- Novo Nordisk today presented results from RESCUE, a phase 2 randomised, double-blind, placebo controlled clinical trial assessing the effect of...

Source: prnewswire.com

Related Topics:

New JerseyUnited StatesPaulm RidkerMartin Holst LangeMatt DevalarajaDiabetes Technology TherapeuticsKidney InternationalAmerican College Of CardiologyWorld Health OrganizationDevelopment At Novo NordiskCirculation ResearchNovo NordiskAmerican CollegeAnnual ScientificCardiovascular Disease PreventionCorvidia TherapeuticsPublished Online MayGlobal BurdenKidney DiseaseDisease StudyEvaluate ReductionVascular Disease ConferenceWriting Groupபுதியது ஜெர்சிஒன்றுபட்டது மாநிலங்களில்